• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Pharma Fever Grips Dealmakers Despite M&A Spike and a Frenzy IPO Year

Share:

January 22, 2022

Several high-profile investment bankers opted to stay out of the dealmaking business to join more strategic roles in the last 12-18 months, despite record M&A volumes and a frenzy IPO year that resulted in record fee collection for dealmakers.

The move was more evident in the pharma sector, where the pandemic opened up a plethora of consolidation and fundraising opportunities.

More than a dozen top bankers moved to strategic and M&A roles in pharmaceutical companies, spearheading mergers and acquisitions as well as fundraising plans. They included Nitin Tandon, who joined as head of business development, Asia Pacific, at Johnson & Johnson from Credit Suisse. Moelis & Co’s Ashish Mukkirwar joined Glenmark to head its strategy and M&A team, while very recently, a prolific pharmaceuticals banker at O3 Capital, Gawir Baig, moved to play the role of a chief financial officer at Anthem Biosciences, a drug discovery platform in which True North recently invested. V Krishnakumar was another high-profile move; he left EY after a long tenure of consistent healthcare M&A closures to join Eris Life Sciences as its chief operating officer.

“Pharma is seeing a lot of M&A and fundraise activity, leading to demand I-banking talent in these companies,” said Anshul Lodha, regional director at recruitment firm Page Group. “I-bankers are also keen to switch to the corporate side to get more well-rounded exposure than just fundraising. They get actively involved in the operational side of the business with corporates which is a great role enhancement for them,” Lodha said.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Read more here

Source: Economictimes

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Khiron enters Uruguay cannabis market via NettaGrowth buyKhiron enters Uruguay cannabis market via NettaGrowth buy
  • Genective and Agbiome Announce Strategic PartnershipGenective and Agbiome Announce Strategic Partnership
  • 5 Big Pharma Showdowns To Watch5 Big Pharma Showdowns To Watch
  • Raising the Bar for COVID-19 Data Integrity and Disease SurveillanceRaising the Bar for COVID-19 Data Integrity and Disease Surveillance
  • New World Resource Corp. and Perimeter Medical Imaging, Inc. Propose Reverse TakeoverNew World Resource Corp. and Perimeter Medical Imaging, Inc. Propose Reverse Takeover
  • Global Neurological Biomarkers Market (2021-2028): Increased Funding for R&D in Biomarkers Expected to Propel Market Growth – ResearchAndMarkets.comGlobal Neurological Biomarkers Market (2021-2028): Increased Funding for R&D in Biomarkers Expected to Propel Market Growth – ResearchAndMarkets.com
  • U Maryland Campuses Partner on AI, Cybersecurity for Medical DataU Maryland Campuses Partner on AI, Cybersecurity for Medical Data
  • MercachemSyncom Closes Acquisition of Alcami WeertMercachemSyncom Closes Acquisition of Alcami Weert

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications